Gsk (GSK) Total Debt Growth (3y) (2012 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Total Debt Growth (3y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
31.94% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
1.29% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
1.29% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
16.90% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
-2.37% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
-4.22% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
21.55% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
5.53% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
3.11% |
| Date | Value |
|---|
| Mar 31, 2026 |
1.32% |
| Dec 31, 2025 |
-48.03% |
| Sep 30, 2025 |
3.05% |
| Jun 30, 2025 |
3.24% |
| Mar 31, 2025 |
-12.91% |
| Dec 31, 2024 |
-9.20% |
| Sep 30, 2024 |
11.03% |
| Jun 30, 2024 |
11.38% |
| Mar 31, 2024 |
11.56% |
| Dec 31, 2023 |
-11.23% |
| Jun 30, 2023 |
11.95% |
| Mar 31, 2023 |
10.70% |
| Dec 31, 2022 |
-11.78% |
| Sep 30, 2022 |
6.60% |
| Jun 30, 2022 |
5.93% |
| Mar 31, 2022 |
19.26% |
| Dec 31, 2021 |
-4.66% |
| Sep 30, 2021 |
3.37% |
| Jun 30, 2021 |
4.46% |
| Mar 31, 2021 |
-13.83% |
| Dec 31, 2020 |
14.56% |
| Jun 30, 2020 |
-19.65% |
| Mar 31, 2020 |
-15.71% |
| Dec 31, 2019 |
10.25% |
| Sep 30, 2019 |
-11.84% |
| Jun 30, 2019 |
-9.21% |
| Mar 31, 2019 |
-18.04% |
| Dec 31, 2018 |
50.99% |
| Sep 30, 2018 |
-18.92% |
| Jun 30, 2018 |
-21.97% |
| Mar 31, 2018 |
-4.42% |
| Dec 31, 2017 |
41.72% |
| Sep 30, 2017 |
-3.51% |
| Jun 30, 2017 |
5.41% |
| Mar 31, 2017 |
1.23% |
| Dec 31, 2016 |
42.14% |
| Sep 30, 2016 |
-3.05% |
| Jun 30, 2016 |
-2.23% |
| Mar 31, 2016 |
5.67% |
| Dec 31, 2015 |
-273.50% |
| Sep 30, 2015 |
-3.63% |
| Jun 30, 2015 |
-1.53% |
| Mar 31, 2015 |
-7.01% |
| Dec 31, 2014 |
-282.48% |
| Sep 30, 2014 |
0.17% |
| Jun 30, 2014 |
-4.32% |
| Mar 31, 2014 |
-2.34% |
| Dec 31, 2013 |
-4.62% |
| Sep 30, 2013 |
-1.76% |
| Jun 30, 2013 |
-5.96% |
| Mar 31, 2013 |
-4.22% |
| Dec 31, 2012 |
26.39% |
| Sep 30, 2012 |
5.15% |
| Jun 30, 2012 |
-2.04% |
| Mar 31, 2012 |
4.61% |
